Subject: REMINDER: GBD 2020 Demography Preliminary Estimates
From: GBD Secretariat <[email-masked]>
To: Ketevan Goginashvili <[email-masked]>
Date: Wed, 01 Apr 2020 15:18:17 +0000

Dear Collaborators,

Reminder, we would like to share with you for your review preliminary population, mortality, and fertility results for GBD 2020.

We know that these are complicated times, and that many of you may have limited ability to review these estimates. We share these preliminary estimates now as part of meeting our commitments to you, as GBD Collaborators, and to producing regular updates to the Global Burden of Disease study. Baseline and benchmark population health numbers to support evidence-based decision-making are more important than ever, and we maintain our dedication to producing these.

Some of you may not be able to review these as you face other commitments in this complicated time; we thank you for being a GBD Collaborator, absolutely understand that you may not be able to participate at this time, and wish you all luck in your work. For those of you who are able to comment, we appreciate any feedback that you are able to provide, and thank you for input. We will continue to open other feedback opportunities throughout the GBD 2020 cycle, and look forward to working with each of you when and how you are able.

The details for the GBD 2020 Demographic preliminary estimates commenting process are below. Thank you for being part of the Collaborator Network, and please do not hesitate to reach out.

Sincerely,
GBD Secretariat

We invite you to review the countries of your interest or expertise as part of the opportunities available exclusively to GBD Collaborators.

Please review these results and submit any comments using the form linked below by midnight Pacific Time, Friday, April 3, 2020.

I. Reviewing the Preliminary Results

To enable you to share feedback as efficiently and easily as possible, we have framed four critical questions regarding these results. We would greatly appreciate your feedback on these questions for the country or countries that you have expert knowledge.

The questions are:

Are there cases where the level or trend of population, mortality, or fertility does not match the data or the demographic profile of that country or location?

Are there sources that we have included that should be marked as outliers (due to unreliable data collection, unrepresentative samples, or other concerns)?

Additionally, looking towards GBD 2021, are there additional sources that are not currently represented in the results that are important to incorporate?

We would ask that you please review your country's completeness results. After reviewing your country's completeness results, are there any issues we should be aware of?

II. Accessing the Preliminary Results

These preliminary results are shared via excel tables and PDFs. In order to access the results, please visit:

Link: https://cloud.ihme.washington.edu/index.php/s/gndQnWYNYLbPYmB

Password: GBD2020Demography

Included in the cloud folder for your country are the following:

Excel tables showing population, total fertility rate, total number of deaths, life expectancy at birth, under-5 mortality rate (5q0), and adult mortality rate (45q15).

Graphs with a variety of outputs, each labeled. These graphs also show the input data points, and model diagnostics for the estimation process.

Please kindly review the preliminary results by midnight Pacific Time, Friday, April 3, 2020 and respond to the questions at the link provided: https://uwhealthmetrics.co1.qualtrics.com/jfe/form/SV_d4E3HMAnSprxx7D?Q_DL=SiWRjPpimBuvb0W_d4E3HMAnSprxx7D_CGC_Hu3jvRgMZJM5TL3&Q_CHL=email

On that date, we will close access to the password-protected site in order to incorporate suggestions and produce new results. Due to the annual GBD timeline, we will be unable to incorporate any changes requested after this date. Regardless, we will review all comments in detail, and suggestions will be taken into consideration for GBD 2021 and beyond.

Lastly, please remember that you are receiving privileged access to these preliminary results as a GBD collaborator; these results are confidential and should not be cited or circulated.

Thank you again for your collaboration. We look forward to improving these results with your help.

Note, by Clicking "Opt Out" you will no longer receive any emails regarding authorship or draft manuscripts/preliminary results to review. If you are instead interested in updating your areas of expertise or your affiliations, or you have any other questions, please contact the GBD Secretariat at [email-masked]

Opt out